Adnews

Please login to continue

Username:

Password:

Adnews offers non-subscribers free access to one story per month.

Subscribe for unrestricted access to our content.

Forgot your login or password? Click here.

LACROIX BLEAU HAS THE ANSWER TO MIGRAINE HEADACHES

Montreal-based LACROIX bleau Communications and Marketing is no longer suffering from migraine headaches after winning the STADOL NS account from Bristol-Myers Squibb of Montreal. The agency received the mandate to promote the migraine treatment after establishing a relationship with BMS two months earlier. LACROIX had competed in a competition with 3 unnamed agencies in January to win the OTC brand. When BMS was interested in a new agency for STADOL, LACROIX was contacted. Previously STADOL was promoted by Academie-Ogilvy of Montreal. LACROIX will promote STADOL to health professionals using informational materials and print ads in medical journals beginning early May.

The agency has also been recently hired to promote the Verreault naval shipyards account. Verreault is a Canadian shipbuilder with international clie

« Back Next »

Related stories Comments